Results 111 to 120 of about 68,908 (269)

Neuro‐Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets

MedComm, Volume 7, Issue 2, February 2026.
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo, Hui Liu, Yu‐Jing Song, Jian‐Hua Wang, Danfeng Liu, Zhi‐Wei Zheng, Jia‐Jun Li, Boya Li, An Song, Wei He, Lei‐Lei Yang, Shuo Wang   +11 more
wiley   +1 more source

Clinical Utility of Long-Acting Injectable Risperidone in Schizophrenia and Bipolar I Disorder: A Review of Clinical Studies

Psychology Research and Behavior Management
Francesco Bartoli, Daniele Cavaleri, Ilaria Riboldi, Chiara Alessandra Capogrosso, Giuseppe Carr&#x00E0School of Medicine and Surgery, University of Milano-Bicocca, Monza, 20900, ItalyCorrespondence: Daniele Cavaleri, School of Medicine and Surgery ...
Bartoli F, Cavaleri D, Riboldi I, Capogrosso CA, Carrà G   +4 more
doaj  

Risperidone for the Treatment of Retentive Fecal Incontinence in Children and Adolescents: A Randomize Clinical Trial [PDF]

, 2022
Ghazal Zahed, Somaye Fatahi, Leila Tabatabaee, Kousalya Prabahar, Amirhossein Hosseini   +4 more
openalex   +1 more source

Cognitive Profiles in Adolescents and Young Adults With Co‐Occurring Autism and First‐Episode Psychosis: A Preliminary Neuropsychological Investigation

PsyCh Journal, Volume 15, Issue 1, February 2026.
ABSTRACT Autism spectrum disorder (ASD) and psychosis are traditionally considered distinct psychiatric conditions with divergent developmental trajectories, yet emerging evidence suggests they may share overlapping neurodevelopmental characteristics.
Domily T. Y. Lau, Melody M. Y. Chan, Flora Y. M. Mo, Se‐Fong Hung, Kelly Y. C. Lai, Patrick W. L. Leung, Caroline K. S. Shea   +6 more
wiley   +1 more source

Duplicate Prescription Patterns in Patients With Substance Use Disorders

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT This study sought to investigate the frequency and characteristics of duplicate prescriptions (DPs) in psychiatric inpatients with substance use disorders using a DP classification that differentiates between appropriate DPs (ADPs) and potentially inappropriate DPs (PIDPs). The study was conducted as a monocentric retrospective cross‐sectional
Johannes Heck, Benjamin Krichevsky, Martin Schulze Westhoff, Konstantin Fritz Jendretzky, Martin Klietz, Stephan Greten, Alexander Glahn, Stefan Bleich, Sebastian Schröder   +8 more
wiley   +1 more source

P01.163 For how long can be expected a sustained improvement in schizophrenic patients treated with antipyschotics? A clinical experience with risperidone [PDF]

, 2000
J. Gibert, Julio Bobes, M. Gutiérrez
openalex   +1 more source

Effect of peri‐operative pharmacological interventions on postoperative delirium in patients having cardiac surgery: a systematic review and Bayesian network meta‐analysis

Anaesthesia, Volume 81, Issue 2, Page 274-287, February 2026.
Summary Introduction Postoperative delirium is a common complication following cardiac surgery. Despite its known impact on patient outcomes, effective preventative strategies remain elusive. We aimed to perform a comprehensive Bayesian network meta‐analysis of randomised controlled trials assessing the effect of pharmacological interventions on the ...
Ivo Queiroz, Lucas M. Barbosa, Mariano Gallo Ruelas, Beatriz Araújo, Maria L. R. Defante, Arthur H. Tavares, Cynthia Florencio de Mesquita, Tulio Pimentel, Beatriz Ximenes Mendes, Iuri Ferreira Felix, André Rivera, Rafael Oliva Morgado Ferreira, Helen M. de Oliveira, Bruno B. Righetto, Nathan J. Smischney, Guangyu Tong, Daqing Ma   +16 more
wiley   +1 more source

Cost-Offsets of New Medications for Treatment of Schizophrenia [PDF]

Broad claims are frequently made that new medications will offset all or part of their costs by reducing other areas of Medicaid spending. In this paper we examine the net impact on spending for new drugs used to treat schizophrenia.
Richard G. Frank, Sharon-Lise Normand, Thomas G. McGuire   +2 more
core  

Modeling cerebral palsy in animals

Developmental Medicine &Child Neurology, Volume 68, Issue 2, Page 158-174, February 2026.
Abstract Advancements in the treatment of cerebral palsy depend on animal research. Yet, most animal models have not been fully evaluated for spasticity and dystonia using clinically relevant measures of altered tone or movement patterns, which form the basis for diagnosing people with the condition.
Katharina A. Quinlan, Emily J. Reedich, Elvia Mena Avila, Brendan C. Moline, Landon T. Genry, Megan R. Detloff, Benjamin R. Katholi, Deborah Gaebler‐Spira, Bhooma R. Aravamuthan   +8 more
wiley   +1 more source

Exploring Medicines Optimisation and Safety in the Community Following Mental Health Hospital Discharge: A Qualitative Interview Study

Health Expectations, Volume 29, Issue 1, February 2026.
ABSTRACT Background Medication safety issues may be common following mental health hospital discharge. However, there is little research exploring their aetiology and influencing factors for patients with mental illness and their carers in the community.
Mark Jeffries, Fiona Naylor, Natasha Tyler, Catherine Robinson, Maria Panagioti, Richard N. Keers   +5 more
wiley   +1 more source